CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Teprenone

替普瑞酮 杂质对照品Teprenone Impurities

34 个杂质条目34 impurity entries

本页汇总 替普瑞酮 的 34 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 34 impurity reference standards of Teprenone. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 替普瑞酮(Teprenone)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 分析方法Analytical MethodsHPLC-APCI-MS for the determination of teprenone in human plasma: method and clinical application
    Journal of pharmaceutical and biomedical analysis · 2007 · Ding L et al.  ·  PMID 17482416  ·  DOI

替普瑞酮 —— 原料药与杂质对照品Teprenone — drug substance & impurities

共 35 个条目(含原料药本体)35 items incl. the drug substance
Teprenone structure
原料药 APIAPI
替普瑞酮Teprenone
Teprenone
CAS No.6809-52-5
Chemical FormulaC23H38O
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 1 (Mixture of E/Z-isomers) structure
1
替普瑞酮杂质1 (混合E/Z构型)Teprenone Impurity 1 (Mixture of E/Z-isomers)
Teprenone Impurity 1 (Mixture of E/Z-isomers)
CAS No.762-29-8
Chemical FormulaC18H30O
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 2 structure
2
替普瑞酮杂质2Teprenone Impurity 2
Teprenone Impurity 2
CAS No.1117-52-8
Chemical FormulaC18H30O
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 3 structure
3
替普瑞酮杂质3Teprenone Impurity 3
Teprenone Impurity 3
CAS No.3796-69-8
Chemical FormulaC18H30O
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 4 structure
4
替普瑞酮杂质4Teprenone Impurity 4
Teprenone Impurity 4
CAS No.3953-35-3
Chemical FormulaC18H30O
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 5 structure
5
替普瑞酮杂质5Teprenone Impurity 5
Teprenone Impurity 5
CAS No.1117-51-7
Chemical FormulaC18H30O
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 6 structure
6
替普瑞酮杂质6Teprenone Impurity 6
Teprenone Impurity 6
CAS No.109826-68-8
Chemical FormulaC23H40O
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 7 structure
7
替普瑞酮杂质7Teprenone Impurity 7
Teprenone Impurity 7
CAS No.3796-67-6
Chemical FormulaC23H38O
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 8 structure
8
替普瑞酮杂质8Teprenone Impurity 8
Teprenone Impurity 8
CAS No.3879-24-1
Chemical FormulaC23H38O
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 9 structure
9
替普瑞酮杂质9Teprenone Impurity 9
Teprenone Impurity 9
CAS No.3879-25-2
Chemical FormulaC23H38O
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 10 structure
10
替普瑞酮杂质10Teprenone Impurity 10
Teprenone Impurity 10
CAS No.3796-66-5
Chemical FormulaC23H38O
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 11 structure
11
替普瑞酮杂质11Teprenone Impurity 11
Teprenone Impurity 11
CAS No.3879-23-0
Chemical FormulaC23H38O
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 12 structure
12
替普瑞酮杂质12Teprenone Impurity 12
Teprenone Impurity 12
CAS No.3796-65-4
Chemical FormulaC23H38O
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 13 structure
13
替普瑞酮杂质13Teprenone Impurity 13
Teprenone Impurity 13
CAS No.70901-63-2
Chemical FormulaC20H32
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 14 structure
14
替普瑞酮杂质14Teprenone Impurity 14
Teprenone Impurity 14
CAS No.3796-63-2
Chemical FormulaC23H38O
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 18 structure
18
替普瑞酮杂质18Teprenone Impurity 18
Teprenone Impurity 18
CAS No.3879-62-7
Chemical FormulaC20H34O
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 19 structure
19
替普瑞酮杂质19Teprenone Impurity 19
Teprenone Impurity 19
CAS No.3879-61-6
Chemical FormulaC20H34O
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 20 structure
20
替普瑞酮杂质20Teprenone Impurity 20
Teprenone Impurity 20
CAS No.3790-76-9
Chemical FormulaC20H34O
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 24 structure
24
替普瑞酮杂质24Teprenone Impurity 24
Teprenone Impurity 24
CAS No.3796-64-3
Chemical FormulaC23H38O
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 25 structure
25
替普瑞酮杂质25Teprenone Impurity 25
Teprenone Impurity 25
CAS No.68931-30-6
Chemical FormulaC20H34O
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 32 structure
32
替普瑞酮杂质32Teprenone Impurity 32
Teprenone Impurity 32
CAS No.158734-06-6
Chemical FormulaC23H40O
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 42 structure
42
替普瑞酮杂质42Teprenone Impurity 42
Teprenone Impurity 42
CAS No.1424-83-5
Chemical FormulaC15H26O2
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 43 structure
43
替普瑞酮杂质43Teprenone Impurity 43
Teprenone Impurity 43
CAS No.58865-88-6
Chemical FormulaC15H24O2
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 44 structure
44
替普瑞酮杂质44Teprenone Impurity 44
Teprenone Impurity 44
CAS No.72523-47-8
Chemical FormulaC15H26O2
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 45 structure
45
替普瑞酮杂质45Teprenone Impurity 45
Teprenone Impurity 45
CAS No.72523-45-6
Chemical FormulaC15H26O2
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 46 structure
46
替普瑞酮杂质46Teprenone Impurity 46
Teprenone Impurity 46
CAS No.72523-46-7
Chemical FormulaC15H26O2
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 47 structure
47
替普瑞酮杂质47Teprenone Impurity 47
Teprenone Impurity 47
CAS No.72523-44-5
Chemical FormulaC15H26O2
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 48 structure
48
替普瑞酮杂质48Teprenone Impurity 48
Teprenone Impurity 48
CAS No.77286-42-1
Chemical FormulaC18H30O2
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 49 structure
49
替普瑞酮杂质49Teprenone Impurity 49
Teprenone Impurity 49
CAS No.123730-51-2
Chemical FormulaC18H30O2
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 50 structure
50
替普瑞酮杂质50Teprenone Impurity 50
Teprenone Impurity 50
CAS No.1051940-05-6
Chemical FormulaC18H30O2
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 69 (Mixture of E/Z-isomers) structure
69
替普瑞酮杂质69 (混合E/Z构型)Teprenone Impurity 69 (Mixture of E/Z-isomers)
Teprenone Impurity 69 (Mixture of E/Z-isomers)
CAS No.112162-99-9
Chemical FormulaC19H30O3
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 70 structure
70
替普瑞酮杂质70Teprenone Impurity 70
Teprenone Impurity 70
CAS No.57766-68-4
Chemical FormulaC20H34
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 71 structure
71
替普瑞酮杂质71Teprenone Impurity 71
Teprenone Impurity 71
CAS No.1206897-24-6
Chemical FormulaC24H38O3
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 72 structure
72
替普瑞酮杂质72Teprenone Impurity 72
Teprenone Impurity 72
CAS No.28374-86-9
Chemical FormulaC6H9Cl
Purity>95%询价On request
10mg25mg50mg100mg
Teprenone Impurity 73 structure
73
替普瑞酮杂质73Teprenone Impurity 73
Teprenone Impurity 73
CAS No.6699-20-3
Chemical FormulaC20H36O7P2
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

替普瑞酮 —— 研究文献与合成路线Teprenone — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 替普瑞酮 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Teprenone. Titles link to the original records; copyright remains with the authors and publishers.

合成与制备工艺专利Synthesis & process patents

  1. Synthesis of Teprenone
    QINGLE ZENG · 公开号 CN101343219CN101343219 · 2009
  2. A PROCESS FOR PREPARING TEPRENONE
    RHEE HAK JUNE, BYUN EUN YOUNG · 公开号 KR20080111777KR20080111777 · 2008
  3. TEPRENONE PREPARATION AND METHOD FOR PRODUCING TEPRENONE PREPARATION
    FUKAMIZU HIROAKI, TOMONO KAZUO, SUZUKI TOYOJI, FURUISHI YOSHIYUKI · 公开号 JP2007217318JP2007217318 · 2007
  4. Application of teprenone for preparing medicine for treating and/or preventing glaucoma
    WANG NINGLI ZHAO · 公开号 CN1903188CN1903188 · 2007

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

替普瑞酮 杂质谱研究要点Teprenone — impurity profiling notes

下面这些是拿到 替普瑞酮 的 35 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 35 impurity entries for Teprenone, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances